| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 71045 |
Radiologic examination, chest; single view |
19,456 |
13,227 |
$100K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,911 |
4,415 |
$99K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,926 |
1,802 |
$83K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,295 |
1,208 |
$52K |
| 71046 |
Radiologic examination, chest; 2 views |
5,440 |
5,355 |
$33K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,832 |
1,773 |
$25K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,343 |
1,297 |
$21K |
| 76801 |
|
898 |
872 |
$20K |
| 93970 |
|
510 |
464 |
$12K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
488 |
483 |
$12K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
251 |
247 |
$5K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
398 |
394 |
$4K |
| 73630 |
|
584 |
560 |
$3K |
| 73562 |
|
357 |
325 |
$3K |
| 76770 |
|
181 |
173 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
144 |
144 |
$2K |
| 93971 |
|
239 |
228 |
$2K |
| 74018 |
|
462 |
358 |
$2K |
| 73130 |
|
406 |
380 |
$2K |
| 71250 |
|
100 |
97 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
53 |
53 |
$2K |
| 73610 |
|
308 |
295 |
$2K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
29 |
27 |
$2K |
| 76830 |
Ultrasound, transvaginal |
61 |
61 |
$1K |
| 73030 |
|
151 |
142 |
$999.22 |
| 71020 |
|
125 |
74 |
$998.66 |
| 71010 |
|
130 |
113 |
$797.26 |
| 73110 |
|
100 |
98 |
$515.05 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$273.64 |
| 73502 |
|
12 |
12 |
$65.59 |
| 76937 |
|
16 |
12 |
$21.39 |
| 0301 |
|
93 |
77 |
$0.00 |
| 0270 |
|
2,224 |
1,307 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
60 |
56 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,208 |
1,108 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
125 |
118 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
88 |
80 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
14 |
14 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
454 |
420 |
$0.00 |
| J3490 |
Unclassified drugs |
1,248 |
671 |
$0.00 |
| 0306 |
|
45 |
40 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
161 |
148 |
$0.00 |
| 81001 |
|
459 |
429 |
$0.00 |
| 83690 |
|
67 |
64 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
113 |
105 |
$0.00 |
| 0250 |
|
394 |
305 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
53 |
52 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
290 |
276 |
$0.00 |
| 86803 |
|
30 |
29 |
$0.00 |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
216 |
101 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
82 |
80 |
$0.00 |
| 85730 |
|
12 |
12 |
$0.00 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
29 |
24 |
$0.00 |
| 0305 |
|
100 |
87 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
36 |
34 |
$0.00 |
| 0307 |
|
13 |
12 |
$0.00 |
| 84484 |
|
31 |
26 |
$0.00 |
| 0450 |
Emergency room services |
5,447 |
4,652 |
$0.00 |
| 0300 |
|
88 |
74 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
175 |
153 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
454 |
419 |
$0.00 |
| 81025 |
|
358 |
333 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
58 |
52 |
$0.00 |
| 85610 |
|
13 |
13 |
$0.00 |
| 85520 |
|
12 |
12 |
$0.00 |
| 81003 |
|
128 |
124 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
14 |
14 |
$0.00 |
| 0760 |
|
13 |
13 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12 |
12 |
$0.00 |